Circulating CD45+EpCAM+ cells as a diagnostic marker for early-stage primary lung cancer

Circulating CD45+EpCAM+ cells as a diagnostic marker for early-stage primary lung cancer

Lung cancer is a highly prevalent type of cancer, accounting for 11.6% of all cancer incidences. Early detection and treatment can significantly improve the survival rate and quality of life of patients; however, there is no accurate, effective, and easy-to-use test for early lung cancer screening....

Full description

Bibliographic Details
Main Authors: Zhen Sun, Peng Li, Zhaojun Wu, Bin Li, Wenjing Li, Mingming Zhao, Xiaobin Zhou, Zeyao Wang, Zhongjie Yu, Wenna Liu, Wenshu Zhu, Haibo Wang, Yongjie Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Medical Technology
Subjects:
lung cancer
PBMCs
CD45+ EpCAM+ cells
CEA
diagnosis
Online Access:https://www.frontiersin.org/articles/10.3389/fmedt.2022.982308/full

Internet

https://www.frontiersin.org/articles/10.3389/fmedt.2022.982308/full

Similar Items